CBD, a compound derived from the cannabis plant, is widely used for its potential health benefits, such as reducing anxiety and inflammation. However, some users have reported feeling that CBD has had an "addictive" or "too strong" effect on them, even though CBD itself does not produce the psychoactive high associated with cannabis. These reports have raised concerns about the safety and purity of CBD products available on the market. Some experts believe that the unexpected effects users are experiencing may be due to the presence of synthetic or semi-synthetic cannabinoids in CBD products. These substances are designed to mimic the effects of cannabis and are often created in laboratories. Unlike natural CBD, these synthetic compounds can have more potent and unpredictable effects on the body. In France, the sale and distribution of certain synthetic cannabinoids are illegal. However, some wholesalers have found ways to bypass these regulations, producing and distributing these substances across Europe. These toxic molecules are sometimes mixed with CBD products, making it difficult for consumers to know exactly what they are taking. Each year, dozens of new synthetic cannabinoids are developed in Europe, further complicating efforts to regulate and monitor their use. As a result, there is growing concern among health professionals and regulators about the potential risks associated with these substances, especially when they are unknowingly consumed alongside CBD.